Home Headlines FTSE 100 climbs on smaller-than-expected GDP contraction, GSK rebound
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

FTSE 100 climbs on smaller-than-expected GDP contraction, GSK rebound

by uma

By Sruthi Shankar

(Reuters) – London’s FTSE 100 rose on Friday after data showed Britain’s economy contracted less than feared in the second quarter, while drugmaker GSK steadied after heavy selling this week on litigation concerns.

The FTSE 100 rose 0.6% and was on course for a fourth straight weekly gain, while the FTSE 250 midcap index edged up 0.1%, also set for a weekly rise.

The Office for National Statistics said the UK’s gross domestic product fell by 0.1% in the June quarter, compared with forecasts for a 0.3% drop.

However, the data still pointed to growing weakness among consumer-facing sectors of the economy, like retail and restaurants, that are most exposed to a worsening cost-of-living crisis.

“The fall in UK GDP during the second quarter was largely down to noise,” James Smith, economist at ING wrote in a note.

“But the risk of recession is rising quickly, with gas futures hitting new highs for next winter and our latest estimates suggesting the household energy price cap could come close to 5,000 pounds in the second quarter of next year. Much now depends on fiscal policy announcements in the autumn.”

Sterling lost 0.4%, supporting the dollar earners on the FTSE 100 including oil majors Shell and BP. Nearly two-third of the revenue from FTSE 100 companies are made overseas.

(Graphic: Looming recession, https://graphics.reuters.com/GLOBAL-MARKETS/THEMES/akpezkowevr/chart_eikon.jpg)

Drugmaker GSK rose 3.0% after shedding about 16% in the past two sessions on concerns about U.S. litigation focused on a heartburn drug that contained a probable carcinogen.

GSK said on Thursday there is no evidence of a causal association between therapy with the heartburn drug ranitidine and the development of cancer in patient. Haleon, GSK’s recently spun-off consumer health unit, edged 0.3% higher.

Flutter jumped 10.5% after the world’s largest online betting firm said it expected to finish the year ahead of 2021 excluding an expected final year of losses in its fast growing U.S. business.

At the bottom of the midcap index was 888 Holdings Plc, which fell 8.3% after the bookmaker reported a fall in its first-half interim profit, dented by tightened UK online gambling safety measures and the cost-of-living crisis.

 

(Reporting by Sruthi Shankar in Bengaluru; Editing by Subhranshu Sahu and Uttaresh.V)

 

You may also like